Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPIRE trial of etanercept and methotrexate in early inflammatory arthritis
2005-005467-29Phase 3Completed
- Sponsor
- University of Leeds
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of etanercept and methotrexate in autoimmune arthritis and rheumatoid arthritis (RA), sponsored by University of Leeds. Started Feb 2006; status: completed.
02
Drugs
etanerceptmethotrexate
03
Conditions
autoimmune arthritisrheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2005-005467-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005467-29.